X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Packaging & Logistic

Quick Opens New Cell and Gene Therapy Center of Excellence Logistics Facility

Content Team by Content Team
4th June 2019
in Packaging & Logistic, Press Statements
Quick  logistics

As the trend for cell and gene therapies are becoming a commercial reality with recent FDA approvals, Quick, part of the Kuehne + Nagel Group, has opened a Cell and Gene Therapy (CGT) logistics facility in order to provide comprehensive logistics solutions and highest performance standards to support the life science community.

While healthcare and life science logistics is complex for all types of medical shipments, gene, cell, and immunotherapies have special challenges, and the logistics need to be synchronized throughout the supply chain to ensure product integrity, patient safety, and successful outcomes.

Cell and gene therapy treatments are different for each patient and require individual handling and precise timing. These new therapies are also high value, extremely time and temperature-sensitive, and require specialized handling, packaging, and proper storage.

Quick’s new 30,000 square foot state-of-the-art CGT Center of Excellence is located in Chicago, IL, with proximity to Chicago’s O’Hare airport. Designed for GDP (Good Distribution Practices) compliance, it has controlled room temperature in-transit storage and is a conditioning and storage facility for Credo units and nitrogen shippers, used for transport of CGT therapies.

Life science logistics specialists will provide clients with 24/7 customized solutions –from specially designed processes, pre-planning of routings, packaging procurement, conditioning and placement to regulatory compliance and temperature monitoring devices. Quick’s advanced IT solutions provide transparency, data integration, and real-time information.

“Quick’s investment in our new cutting edge CGT facility, recruitment of highly experienced logistics specialists and innovative technology solutions to synchronize the CGT supply chain reflects our commitment to support the life science community. We are proud to partner with pharmaceutical and biotech companies that are developing these exciting new therapies and provide them comprehensive logistics support,” says David Murphy, Executive Vice President, Quick Specialized Healthcare Logistics.

About Quick Specialized Healthcare Logistics
Quick is the trusted logistics leader for the healthcare and life science industry, serving the community for nearly 40 years. Quick, part of the Kuehne + Nagel Group safely and quickly transports human organs and tissue for transplant or research, blood, blood products, cord blood, bone marrow, medical devices, and equipment, as well as cell and gene therapies.

About Kuehne + Nagel
With almost 82,000 employees at more than 1,300 locations in over 100 countries, the Kuehne + Nagel Group is one of the world’s leading logistics companies. Its strong market position lies in the seafreight, airfreight, contract logistics, and overland businesses, with a clear focus on providing IT-based integrated logistics solutions. Further information can be found at www.kuehne-nagel.com

Previous Post

CRF Bracket's World-Class Clinical Research Technology wins European PIN Award for Second Year in Row

Next Post

Hamilton And Enable Biosciences Team Up to Automate Ultra-Sensitive Antibody Detection Assay Platform

Related Posts

ACHEMA
Middle East and South Asia

ACHEMA Middle East to Debut in Riyadh in 2026 Trade Show

9th May 2025
Press Statements

APM Steam Highlights Comprehensive HVAC Insulation Services for Biopharmaceutical and Pharmaceutical Facilities

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Americas

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

4th March 2025
Drug Development

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

4th March 2025
Drug Development

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

4th March 2025
Next Post
liquid biopsy samples

Hamilton And Enable Biosciences Team Up to Automate Ultra-Sensitive Antibody Detection Assay Platform

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In